Paperpal Prime Logo

Expert Review of Endocrinology and Metabolism : Impact Factor & More

eISSN: 1744-8417pISSN: 1744-6651

Key Metrics

CiteScore
5.4
SJR
Q3Endocrinology, Diabetes and Metabolism
SNIP
0.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Expert Review of Endocrinology and Metabolism

Expert Review of Endocrinology and Metabolism Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • SJR SJR
Overview
Publisher ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
Language English
Frequency Quarterly
General Details
LanguageEnglish
FrequencyQuarterly
Publication Start Year2006
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Expert Review of Endocrinology and Metabolism ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Expert Review of Endocrinology and Metabolism

Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues
  • 6 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Crinecerfont: emerging role in the management of congenital adrenal hyperplasia
  • 6 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Targeting kidney disease in type 1 diabetes: progress and promise
  • 3 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Improving outcomes through early diagnosis and care in diabetes during pregnancy: are we doing enough?
  • 27 Jul 2026
  • Expert Review of Endocrinology & Metabolism
Do women with young-onset type 2 diabetes have a higher risk for adverse pregnancy outcomes?
  • 24 Jul 2026
  • Expert Review of Endocrinology & Metabolism
Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes
  • 4 Jul 2026
  • Expert Review of Endocrinology & Metabolism
Resmetirom and semaglutide: next-generation therapies for metabolic-associated steatohepatitis. Opportunities, challenges and issues
  • 6 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Crinecerfont: emerging role in the management of congenital adrenal hyperplasia
  • 6 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Targeting kidney disease in type 1 diabetes: progress and promise
  • 3 Aug 2026
  • Expert Review of Endocrinology & Metabolism
Improving outcomes through early diagnosis and care in diabetes during pregnancy: are we doing enough?
  • 27 Jul 2026
  • Expert Review of Endocrinology & Metabolism
Do women with young-onset type 2 diabetes have a higher risk for adverse pregnancy outcomes?
  • 24 Jul 2026
  • Expert Review of Endocrinology & Metabolism
Surgical considerations for adult Graves’ disease: a narrative review of indications, perioperative challenges and postoperative outcomes
  • 4 Jul 2026
  • Expert Review of Endocrinology & Metabolism

FAQs on Expert Review of Endocrinology and Metabolism